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Objectıves: In this study we aimed to investigate whether there is an association
between mean platelet volume (MPV), gamma glutamyl transferase (GGT), uric acid
and coronary artery ectasia (CAE) in a large patient population.
Methods: A total of 406 patients (245 male, mean age 559 years) were selected as
study population in a retrospective manner from 3265 individuals who have under-
gone coronary angiography between August 2011 and December 2012. Study pop-
ulation was consisting of four groups including 117 (%29) patients with isolated CAE,
109 (%27) patients with both CAE and severe stenosis in at least one coronary artery,
104 (%26) patients with isolated signiﬁcant coronary stenosis and 76 (%18)patients
with normal coronary arteries (NCA) as control group. Detailed evaluation of all
coronary angiograms was performed by two experienced interventional cardiologist.
Information regarding blood tests of patients obtained during hospitalisation were
extracted from Institute electronic database.
Results: MPV, GGT, and uric acid levels were signiﬁcantly higher in subjects with
stenotic coronary artery disease (CAD) and in subjects with both CAD and CAE
compared with subjects with isolated CAE and subjects with NCA. There were no
signiﬁcant differences between subjects with isolated CAE and NCA groups in terms
of MPV (8.61.2 fL to 8.61.1, p¼0.993), serum GGT (3315 U/L to 3015 U/L,
p¼0.723) and uric acid levels (5.41.6 mg/dl to 5.21.7 mg/dl, p¼0.845).
Conclusıon: Unlike with previous studies our study failed to demonstrate any asso-
ciation between CAE and MPV, uric acid and GGT levels.PP-312
Low Efﬁciency of the Standard Dosing of Unfractionated Heparin in Patients
NSTEMI Elderly Female and Moderate Chronic Kidney Disease Hospitalized
Within 12 Hours
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Purpose: To study the effectiveness of a standard dose of unfractionated heparin in
patients nSTEMI in a subgroup of elderly women and moderate chronic kidney
disease at a delay of more than 12 hours of hospitalization.C206 JACC VoStudied 306 patients nSTEMI, hospitalized within 12 hours, which were divided
into 4 sub-group: patients 65 years (n¼98) and women (n¼79), patients with
CKD stage 3 (n¼84) and control group (under 65 years, men without CKD 3). All
patients received infusion of unfractionated heparin recommended in the Guidelines
scheme bolus is 4,000 units, followed by infusion of not more 1000U \ hour. Every
6 hours for 48 hours, the measured level of APTT. The target level was 2normal
range of aPTT
Results: In the indicated dosages in the elderly for the ﬁrst 18 hours you can not
achieve the required numbers aPTT. In women, the ﬁrst two indicators (12:00 heparin
therapy) was signiﬁcantly lower than control values (43,41,27 s., p¼0.04 and from
42,12,02, p¼0.009). Further indicators aPTT signiﬁcantly improving and bench-
marking. Subgroup renal disease is more difﬁcult with the correct amount of APTT
(APTT 1 - 41,02,53 s., p¼0.03, aPTT 2 - 40,12,31 s., p¼0.004, aPTT 3 -
44,82.14 s., p¼0.02, aPTT 4 -51,41,11 s, p¼0.03, aPTT 5 - 49,32,31 s, p¼0.02.
6 and 7 shows the measurement data comparable to the control, but the eight
measurement was again signiﬁcantly less than control values. Results of the analysis
indicate only about 50% of the patients included in the study, reach a therapeutic aPTT
level in international schemes recommended dosage.
Conclusıons: The proposed internationally recommended dose of UFH in patients
with reduced GFR and the elderly, can not provide the required values of APTT in the
early hours and did not reach the level of anticoagulation observed in the control
group. With late hospitalization in these sub-groups must use higher doses of heparin,
especially in the ﬁrst 12 hours.
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Aım: Coronary care unıts (CCU) are specialised centers for performing monitoriza-
tion, follow-up and treatment of coronary, noncoronary cardiac and other noncardiac
emergencies. We aim to show the features of patients recieving care of coronary unit
and to determine the changes of approach at a tertiary cardiac center in the same time
period more than 10 years apart.
Materıal-Methods: We included all consecutive patients hospitalized in the CCU
between 1998 to 2013. We constitute 2 groups. Group 1 (between 1998 to 2002) had
2041, Group 2 (between 2011 to 2013) had 1181 patients. We compared diagnostic
distributions, features of cases and in-hospital mortality rates between two groups.
Results: The mean age and female gender distribution was 5910 years, 24% in
group 1, 6312 years and 28% in group 2. Group 1 consists of 79% acute coronary
syndromes (ACS) (59% ST elevated (STEMI), 41% nonST elevated); 9% ryhthm and
conduction disturbances; 7% left ventricular heart failure and pulmonary edema; 1.9%
cardiogenic shock and cardiopulmonary arrest; 3% others (Valvular heart diseases,
aortic dissection, digital intoxication, pericardial effusion and tamponate, syncope,
chronic obstructive pulmonary diseases etc.). Group 2 consists of 72% ACS (40%
STEMI, 60% non ST elevated); 13% ryhthm and conduction disturbances; 9% left
ventricular heart failure and pulmonary edema; 1.3% cardiogenic shock and cardio-
pulmonary arrest; 4,7% others (Valvular diseases, aortic dissection, digital intoxica-
tion, pericardial effusion and tamponate, syncope, chronic obstructive pulmonary
diseases etc.) (Table 1).
Overall in-hospital mortality of groups was 9.0% and 4.4% respectively. (Table1)
According to their diagnosis ıt was 6% for ACS (6% for STEMI; 5% for Non ST
elevated) in group 1; 4.3% for ACS (5% for STEMI; 4.1% for Non ST elevated) in
group 2. The revascularization strategy of two groups was different. Thrombolysis
was 92% in group 1, whereas primary percutaneous coronary intervention was 98% in
group 2. CCU length of stay was 6 4 day and 100  15 hours in group 1, 43 day
and 3913 hours in group 2 for all patients and cases with ACS respectively.
Conclusıon: ACS continue to be vast majority of cases in CCU. New pharmacologic
and interventional strategies provide the notable reduction in mortality from ACS. It is
noticed that there is a reduction in STEMI cases and increase in non ST elevation ACS
and also age of ACS cases.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Coronary Care Unit Patient Proﬁle and in-Hospital Mortality
Group 1
(n¼2041)
Group 2
(n¼1181)
Age average (year) 59 63
Female (%) 24 28
Acute coronary syndrome (%) 79 72
ST elevated ACS (All of ACS) (%) 59 40
Non ST elevated ACS (All of ACS) (%) 41 60
Rhythm and conduction abnormalities (%) 9 13
Heart failure and pulmonary edema (%) 7 9
Cardiogenic shock and cardiopulmonary arrest (%) 1,9 1,3
Others (Valvular heart diseases, aort dissection,
pericardial diseases, syncope, pulmonary diseases,
acute pulmonary embolism, etc) (%)
3 4,7
Hospital mortality (%) 9 4,4
Hospital mortality of ACS (%) 6 4,3
Hospital mortality of ST elevated ACS (%) 6 5
Hospital mortality of non ST elevated ACS (%) 5 4,1
Hospital mortality of rhythm and conduction
abnormalities (%)
11 9
Hospital mortality of heart failure and pulmonary
edema (%)
11 8
Hospital mortality of cardiogenic shock and
cardiopulmonary arrest (%)
65 47
Endothelial nitric oxide synthase gene (G894T) polymorphisms genotype and
allel frequencies
CAE
(n:65)
%
Controls
(n:65)
% Pn: n:
GG genotype 22 33.8 41 63.1 0.001
GT genotype 38 58.5 22 33.8 0.005
TT genotype 5 7.7 2 3.1 0.244
GT + TT genotypes
(Dominant genetic
model)
43 66.2 24 36.9 0.001
T allel 48 36.9 26 20 0.004
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Background: Coronary artery ectasia (CAE) is deﬁned as local or generalized
aneurysmal dilatation of the coronary arteries. Although the etiology of CAE has not
been identiﬁed completely, the most frequent cause is coronary atherosclerosis. It is
known that an expansive remodelling occurs in atherosclerotic coronary arteries due to
plague rupture and increased plague burden particularly in early stages. Endothelial
nitric oxide synthase (eNOS) has important role in modulating smooth muscle tonus
and vessel diameter. Polymorphism of the eNOS (G894T) gene has been associated
with altered function of this gene and its products. Experimental and clinical data
suggesting that; in the absence of eNOS, endothelial functions and luminal remodeling
is impaired, the vessel wall thickness is increased, atherosclerosis accelerated and got
complicated.In this study, we investigated the eNOS gene polymorphism (G894T) in
patients with CAE.
Methods: Sixty ﬁve patients with isolated CAE (mean age 537 years) and 65
controls with normal coronary angiograms (mean age 517 years) were included in
the study. eNOS G894T gene polymorphisms were analysed by polymerase chain
reaction and restriction fragment length polymorphism. For each polymorphic posi-
tion, one of three possible patterns may be obtained: Normal (GG) genotype,
heterozygous (GT), or homozygous (TT) mutant genotype. Demographic character-
istics and major risk factors for atherosclerosis were evaluated in the study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. Genotype distribution of CAE and control groups shown in the table. The
frequency of the GT heterozygous genotype was signiﬁcantly higher in CAE group
than controls (38 (%58,5) vs 22 (%33.8), p¼0.005). Between the two groups were
compared according to the dominant genetic model (GT+TT vs. GG), The number of
patients carrying at least one T mutant allele (GT+TT) was signiﬁcantly higher in
CAE than controls (43 (%66.2) vs 24 (%36.9), p¼0.001). With respect to allelic
distribution (G vs T, additive model), the frequency of the T mutant allele was
signiﬁcantly higher in CAE patients. (48 (%36.9) vs 26 (%20), p¼0.004).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-315
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Background: The association of epicardial adipose tissue (EAT) with coronary artery
disease has been shown in previous studies. Furthermore the relationship between
EAT and acute coronary syndrome was studied recently. Herein, we investigated the
relationship between EAT thickness and the Thrombolysis in Myocardial Infarction
(TIMI) risk score for non-ST elevation myocardial infarction (NSTEMI) and unstable
angina pectoris (USAP).
Methods: A total of 144 patients with NSTEMI/USAP were included. Study pop-
ulation was divided into two sub-groups according to TIMI risk scores as group I: 4
(n¼86) and group II: >4 (n¼58). Stepwise multivariable logistic regression analysis
was used to assess the independent association of clinical parameters with TIMI risk
score.
Results: EAT thickness was higher in Group II compared to Group I (8.22.1 vs
6.22.2, p<0.001). Also patients in Group II showed higher rate of multivessel
disease and Gensini score (p<0.001). In univariate linear regression analysis, EAT
was positively correlated with TIMI risk score and Gensini score. Multivariate
regression analysis showed that EAT thickness (OR: 1.56, 95% CI: 1.17-2.08,
p¼0.003), LVEF (OR: 0.93, 95% CI: 0.85-0.98, p¼0.03) and Gensini score (OR:
1.36, 95% CI: 1.24-1.98, p¼0.002) were independently associated with higher TIMI
risk score.
Conclusıon: In conclusion, EAT thickness is independently associated with TIMI risk
score and may be an emerging risk factor for adverse events in NSTEMI/USAP.ERS C207
